Background Different studies have assessed the diagnostic accuracy of EGFR mutation-specific antibodies in non-small cell lung cancer (NSCLC). positive. Molecular-based analyses are essential only when the anti-E746-A750 antibody email address details are negative. Immunohistochemistry seems more desirable for clinical testing for EGFR mutations to molecular-based evaluation prior. Introduction Lung tumor is the most popular reason… Continue reading Background Different studies have assessed the diagnostic accuracy of EGFR mutation-specific